Improvement in DAS28 response through one-year of golimumab treatment in patients with active RA despite treatment with methotrexate: A phase II, randomized, double blind, placebo controlled, dose ranging trial

Kay, J., Durez, P., Matteson, E. L., Dasgupta, B., Nash, P., Hall, S., Hsia, E. C., Chiruvolu, P., Han, J., & Rahman, M. U. (2007). Improvement in DAS28 response through one-year of golimumab treatment in patients with active RA despite treatment with methotrexate: A phase II, randomized, double blind, placebo controlled, dose ranging trial. Annals of the Rheumatic Diseases, 66, 175-176. https://hdl.handle.net/2078.5/65764 (Original work published 2007)